LINDSAY MCCARTHY: Open Payments
NPI 1184956625 · HELENA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 28 payments from 10 companies in 2025. Trend: 2023 $478 · 2024 $435 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $216 |
| Amgen Inc. | 3 | $52 |
| Lilly USA, LLC | 3 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| LEO Pharma Inc. | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $17 |
| Incyte Corporation | 1 | $16 |
| GENZYME CORPORATION | 1 | $14 |
Products named: SKYRIZI, OTEZLA, TALTZ, DUPIXENT, Sotyktu, ADBRY, TREMFYA, Xolair.
Industry payments across MT — which companies pay providers there.
